Indefinite Delivery Contract SPE2DU25D9434

The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999, is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) and provides worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and the U.S. Naval Fleet.

The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contractor is responsible for furnishing these items in accordance with the specified ordering, packaging, shipping, receiving, and unique requirements outlined in the solicitation. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion for all regions and options. The contract is awarded on a lowest price, technically acceptable basis, and the government intends to use a reverse auction strategy to obtain the best distribution fees from the primary suppliers.